Literature DB >> 33925678

Clinical Pattern of Preoperative Positron Emission Tomography/Computed Tomography (PET/CT) Can Predict the Aggressive Behavior of Resected Solid Pseudopapillary Neoplasm of the Pancreas.

Ji-Su Kim1,2, Emmanuel Ii-Uy Hao3, Seoung-Yoon Rho1, Ho-Kyoung Hwang1,2, Woo-Jung Lee1,2, Dong-Sub Yoon1,2, Chang-Moo Kang1,2.   

Abstract

Predicting the aggressiveness of solid pseudopapillary neoplasms (SPNs) remains an important goal. The present study aimed to identify perioperative factors that can predict patients who will develop clinically aggressive SPN. Records of individuals with pathologically confirmed SPN from 2006 to 2017 were obtained from the patient registry database of Yonsei University, Severance Hospital. For this study, aggressive behavior was defined as SPN that had recurred, metastasized, or involved adjacent organs. A total of 98 patients diagnosed with SPNs were analyzed retrospectively. Of these, 10 were reported to have SPNs with aggressive characteristics. We found that age (≥40 years; p = 0.039), symptomatic presentation (p = 0.001), tumor size (>10 cm; p < 0.001), positron emission tomography/computed tomography (PET/CT) classification (p < 0.001), and lymphovascular invasion (p = 0.003) were significantly correlated with aggressive behavior of SPNs. Multivariate analysis showed that PET/CT configuration (p = 0.002) (exp(β)111.353 (95% confidence interval (CI): 5.960-2081), age ≥40 years (p = 0.015) (exp(β) 23.242 (95% CI: 1.854-291.4)), and lymphovascular invasion (p = 0.021) (exp(β) 22.511 (95% CI: 1.595-317.6)) were the only independent factors associated with aggressive SPN. Our data suggest that age ≥40 years, PET/CT Type III configuration, and lymphovascular invasion are independent factors associated with aggressive SPN. This information can help clinicians develop individualized management and surveillance plans to manage patients more effectively.

Entities:  

Keywords:  aggressive pancreatic cancer; aggressive tumor; pancreas; pancreatic neoplasm; solid pseudopapillary tumor

Year:  2021        PMID: 33925678     DOI: 10.3390/cancers13092119

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  33 in total

1.  Preoperative neutrophil-to-lymphocyte ratio predicts malignancy and recurrence-free survival of solid pseudopapillary tumor of the pancreas.

Authors:  Feng Yang; Yun Bao; Zhongwen Zhou; Chen Jin; Deliang Fu
Journal:  J Surg Oncol       Date:  2019-04-30       Impact factor: 3.454

2.  One Hundred Twenty-One Resected Solid Pseudopapillary Tumors of the Pancreas: An 8-Year Single-Institution Experience at Zhongshan Hospital, Shanghai, China.

Authors:  Yadong Xu; Guochao Zhao; Ning Pu; Abulimiti Nuerxiati; Yuan Ji; Lei Zhang; Yefei Rong; Wenhui Lou; Dansong Wang; Tiantao Kuang; Xuefeng Xu; Wenchuan Wu
Journal:  Pancreas       Date:  2017-09       Impact factor: 3.327

Review 3.  Solid pseudopapillary neoplasm of the pancreas: a rare and atypically aggressive disease among male patients.

Authors:  Matthew Y C Lin; Bruce E Stabile
Journal:  Am Surg       Date:  2010-10       Impact factor: 0.688

4.  Solid-pseudopapillary tumor of the pancreas: a surgical enigma?

Authors:  Robert C G Martin; David S Klimstra; Murray F Brennan; Kevin C Conlon
Journal:  Ann Surg Oncol       Date:  2002 Jan-Feb       Impact factor: 5.344

Review 5.  Prognostic value of Ki-67 in solid pseudopapillary tumor of the pancreas: Huashan experience and systematic review of the literature.

Authors:  Feng Yang; Xinzhe Yu; Yun Bao; Zunguo Du; Chen Jin; Deliang Fu
Journal:  Surgery       Date:  2015-11-24       Impact factor: 3.982

Review 6.  Hyperaccumulation of (18)F-FDG in order to differentiate solid pseudopapillary tumors from adenocarcinomas and from neuroendocrine pancreatic tumors and review of the literature.

Authors:  Zhi-wei Guan; Bai-xuan Xu; Rui-min Wang; Lu Sun; Jia-he Tian
Journal:  Hell J Nucl Med       Date:  2013-05-20       Impact factor: 1.102

Review 7.  Aggressive variant of a solid pseudopapillary neoplasm: a case report and literature review.

Authors:  Bailey A Reindl; Douglas W Lynch; Ali D Jassim
Journal:  Arch Pathol Lab Med       Date:  2014-07       Impact factor: 5.534

8.  Aggressive behaviour of solid-pseudopapillary tumor of the pancreas in adults: a case report and review of the literature.

Authors:  Cosimo Sperti; Mattia Berselli; Claudio Pasquali; Davide Pastorelli; Sergio Pedrazzoli
Journal:  World J Gastroenterol       Date:  2008-02-14       Impact factor: 5.742

9.  A Health Profile of Senior-Aged Women Veterans: A Latent Class Analysis of Condition Clusters.

Authors:  Margaret E Gonsoulin; Ramon A Durazo-Arvizu; Karen M Goldstein; Guichan Cao; Qiuying Zhang; Dharani Ramanathan; Denise M Hynes
Journal:  Innov Aging       Date:  2017-11-20

10.  Survival Analyses for Patients With Surgically Resected Pancreatic Neuroendocrine Tumors by World Health Organization 2010 Grading Classifications and American Joint Committee on Cancer 2010 Staging Systems.

Authors:  Min Yang; Neng-Wen Ke; Yi Zhang; Lin Zeng; Chun-Lu Tan; Hao Zhang; Gang Mai; Bo-le Tian; Xu-Bao Liu
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

View more
  2 in total

1.  Current highlights on solid pseudopapillary neoplasm of the pancreas.

Authors:  Simone Sibio; Sara Di Carlo
Journal:  World J Hepatol       Date:  2022-01-27

2.  Analysis of invasiveness and tumor-associated macrophages infiltration in solid pseudopapillary tumors of pancreas.

Authors:  Jie Yang; Chun-Lu Tan; Dan Long; Yan Liang; Li Zhou; Xu-Bao Liu; Yong-Hua Chen
Journal:  World J Gastroenterol       Date:  2022-09-14       Impact factor: 5.374

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.